You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study
Recruiting
  • Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
  • +17 more
  • Gemcitabine Hydrochloride
  • Jacksonville, Florida
  • +3 more
2022-03-22
Mar 22, 2022
M
Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery
Active, not recruiting
  • Hydronephrosis
  • +18 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-17
Nov 17, 2021
M
Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression
Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-28
Jun 28, 2021
N
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy
Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +19 more
  • Tampa, Florida
    Moffitt Cancer Center
2021-11-30
Nov 30, 2021
N
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +23 more
  • Riverside, California
  • +8 more
2022-04-05
Apr 5, 2022
M
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer - 2019
Completed
Has Results
  • Recurrent Bladder Urothelial Carcinoma
  • +19 more
  • Erlotinib Hydrochloride
  • Houston, Texas
    M D Anderson Cancer Center
2020-08-21
Aug 21, 2020
N
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +21 more
  • Bloomington, Illinois
  • +23 more
2022-04-05
Apr 5, 2022
N
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
Recruiting
  • Locally Advanced Renal Pelvis Urothelial Carcinoma
  • +20 more
  • Duarte, California
  • +15 more
2022-02-02
Feb 2, 2022
E
Propranolol Hydrochloride and Pembrolizumab for the Treatment of Recurrent or Metastatic Urothelial Cancer
Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +13 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
2021-05-24
May 24, 2021
M
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-09-24
Sep 24, 2021
N
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
2022-04-05
Apr 5, 2022
M
A Genotype-Phenotype Urothelial Cancer Registry
Recruiting
  • Urothelial Cancer
  • +3 more
  • saliva sample and questionaire
  • saliva sample, questionaire
  • Basking Ridge, New Jersey
  • +3 more
2021-06-02
Jun 2, 2021
U
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
Active, not recruiting
  • Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter
  • +8 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
2022-01-24
Jan 24, 2022
U
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Recruiting
  • Localized Renal Pelvis and Ureter Urothelial Carcinoma
  • +10 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-21
Dec 21, 2021
M
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer - 2020
Completed
Has Results
  • Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
  • +11 more
  • Scottsdale, Arizona
  • +2 more
2021-03-12
Mar 12, 2021
M
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function - 2015
Completed
Has Results
  • Distal Urethral Cancer
  • +10 more
  • Gemcitabine hydrochloride
  • +3 more
  • Springfield, Missouri
  • +1 more
2020-09-17
Sep 17, 2020
U
Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma
Recruiting
  • Urothelial Cancer of Renal Pelvis
  • Urothelial Carcinoma Ureter
  • Dallas, Texas
    University of Texas Southwestern Medical Center
2021-11-30
Nov 30, 2021
G
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
2021-09-17
Sep 17, 2021
D
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function - 2018
Completed
  • Urothelial Carcinoma
  • +4 more
  • Copenhagen, Denmark
  • +1 more
2019-10-07
Oct 7, 2019
U
Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477) - 2020
Completed
Has Results
  • Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
  • Birmingham, Alabama
  • +2 more
2020-07-24
Jul 24, 2020
S
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Recruiting
  • Transitional Cell Cancer of Renal Pelvis and Ureter
  • padeliporfin VTP
  • New York, New York
  • +2 more
2022-02-07
Feb 7, 2022
D
Sacituzumab Govitecan Plus EV in Metastatic UC
Recruiting
  • Urothelial Cancer
  • +3 more
  • Sacituzumab Govitecan (SG)
  • Enfortumab vedotin-ejfv (EV)
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-10-14
Oct 14, 2021
M
Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer
Recruiting
  • Renal Pelvis and Ureter Urothelial Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
2020-10-21
Oct 21, 2020
H
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer - 2019
Completed
Has Results
  • Bladder Cancer
  • +4 more
  • Tampa, Florida
  • +1 more
2019-06-07
Jun 7, 2019
U
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract - 2008
Completed
  • Bladder Cancer
  • +2 more
  • Avignon, France
  • +10 more
2021-02-18
Feb 18, 2021